The Effect of Probiotic Pill on Oral Mushroom in HIV-positive Patients

Phase 3

• Conditions: Oral Candida.; B37; Candidiasi

• Registration Number: IRCT20170618034619N2
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

HIV positive People who have an Immunological Failure
HIV positive People who have a Positive Salivary Candidate

Exclusion Criteria

HIV positive People with an Immunologic Failure that take Antibiotics
HIV positive people with an Immunologic failure who have taken an Anti-fungal Drug
HIV-positive people with an Immunologic Failure that has consumed Probiotic Products
HIV positive people with an Immunologic Failure who are not Cooperatives

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Candida Colony Count. Timepoint: At the Beginning of the Study (before the Intervention) and 1 Month after taking the Tablet. Method of measurement: CFU with Microbiological laboratory Methods.